NCT01021800Unknown2 期
Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma
Blood Transfusion Centre of Slovenia2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- PROGRESSION FREE SURVIVAL
研究概览
简要总结
Interventional study of modulation of immune response in patients with pancreatic tubular adenocarcinoma after resection and gemcitabine treatment. When included, patients are pre-treated with moderate doses of cyclophosphamide. Then infusions of allogeneic mononuclear cells are given.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ECOG performance status 0-2 at the time of inclusion
- •Following R0 or R1 pancreatic tubular adenocarcinoma resection and adjuvant gemcitabine treatment
排除标准
- •Pregnancy
- •Less than 3 mths expected survival
- •Serious comorbidity
- •Age above 70 yrs
结局指标
主要结局
PROGRESSION FREE SURVIVAL
时间窗: 1 YEAR
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Imunomodulation in Acute PancreatitisAcute PancreatitisNCT04796311Filipa Malheiro80
Unknown
不适用
Evaluation of the Impact of Pancreatectomy on Systemic ImmunityPancreas CancerHyperglycemia PancreatectomyNCT03978702Institut Paoli-Calmettes40
终止
不适用
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for StudyPancreatic NeoplasmsNCT00100321National Cancer Institute (NCI)25
招募中
不适用
Immune monitoring in pancreatic cancerpancreatic ductal adenocarcinoma10017991pancreatic cancerNL-OMON45549Stichting Leveronderzoek400
招募中
不适用
Immune monitoring in pancreatic cancerpancreatic canceralvleesklierkankerNL-OMON27380Foundation for Liver and Gastrointestinal Research (SLO)200